Document LpGB0917QrNeExG0Zg8Ypr00z

efpia BB cscs bY Chemicals Strategy for Sustainability and Medicinal Products: How the EU Chemicals Legislation Interlinks with the EU Pharmaceutical Sectoral Legislation Tchie iantPernodoufcitssDnifocrtapi2c00i 10/8s3h,owwthihchkaarg2 betawmeeenndeRdEceA8nCCtL.H,PErUopcoshalesmonitmeanragfemenotf tlheiRsEtACoHaAnudttohrespartiosniaonnds oRfeshtreicMtieon wroeceenssewcitlorrseqsuierce chaenggsesattoonmasrukcehti5ngmeaudtihcorailsaptironodaslealiatnioonf amendictihenaRlEPArCodHucetsf.orTHne cunentpeontdenetdiaclodnsserquuepnicnesinofpattheisntovceressp bse iayt0onmesdicoinnetsh.e AEsstenhtiatleUsoefCcooncmeppltaainnd,thhiesxnefongoranphiocf GreensreentAspporuoracbhesot iinstekrpMraentaatgieonmeofntformation provided during skehder on Em EE 5 APPLICANT = pl EU AGENCY APPLICANT [| rossi in| Sr) omit Qo ECHA = CT NE | TeerreeermarmpaaermerteseseoyESe ee e mSe eemeeeeBsedEb epdeeeE Peee eeE FeengsT eC teaEn ee Te seoae 5 B Omkro evict LVEB ryvrs anstonficspI reEdO parr et ret El thaaea eeodUeSRnRtomo54srs fom gn od ain. SO Eseth getetasaecshromsao n rrat e iebrA 9 on d etS cY t Aft tsa crbogat tns mee r sa somase iA boSHSoaeap re aeae tras ar 1] stow meR if es ne H mel te,er Fmd TlTE m ee r eaetee A Se met PEL are ee 590 || pooooryoetpot e towntirg eeh ee ateer ,ea aoa arneg AsboYeaneaas vpedd Coaetsooimgy ocrioeteto| 8nCtotonneaiEgEio So me aSpec vCWeas nreoaaCnont| =EAonPtocdStby Ry |